Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
ConditionNASH - Nonalcoholic Steatohepatitis
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-75
SponsorPerspectum
About this trial
To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without.
Eligibility criteria
Qualifiers
Male and Female subjects aged between 18 and 75 years old
Ability to understand and sign a written informed consent forms
Patients scheduled to undergo a standard of care diagnostic liver biopsy as follows
Percutaneous biopsy with a 16 gauged needle passed into the right lobe
Disqualifiers
Prior histopathological diagnosis of NASH
Inability to undergo a liver biopsy
Prior or planned liver transplantation
Patient scheduled to undergo a laparoscopic or wedge liver biopsy or biopsy taken from the left lobe
Trial design
Treatments tested in this trial
- Liver Multi Scan
Treatment groups
225 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov